Question 77

Cyclosporine is prescribed to prevent the likelihood of rejection following a recent kidney transplant.

Cyclosporine is an immunosuppressive medication commonly used to prevent organ rejection in transplant patients, particularly following kidney transplants. It works by inhibiting the activity of T cells, which are part of the immune response that can attack the transplanted organ.

A) Captopril

Captopril is an ACE inhibitor primarily used to treat hypertension and heart failure. While it may have some protective effects on the kidneys, it is not indicated for preventing organ rejection in transplant patients. Therefore, it is not suitable for this purpose.

B) Cyclosporine

Cyclosporine is specifically designed to suppress the immune system and reduce the risk of rejection after organ transplants, including kidney transplants. Its effectiveness in this role makes it the preferred choice among transplant medications.

C) Cephalexin

Cephalexin is an antibiotic used to treat bacterial infections. It does not have immunosuppressive properties and is not used to prevent organ rejection. Its role is entirely different and unrelated to transplant management.

D) Citalopram

Citalopram is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is not utilized for preventing organ rejection and does not have any immunosuppressive effects. Thus, it is irrelevant in the context of kidney transplantation.

Conclusion

Cyclosporine is the definitive medication for preventing rejection after a kidney transplant due to its immunosuppressive properties. All other options either serve entirely different medical purposes or lack the necessary properties to address organ rejection effectively. Therefore, Cyclosporine stands out as the appropriate choice in this scenario.